Page Content
Tumor-infiltrating lymphocytes (TIL) Modular Facility consists of 10 prefabricated Germ-Free modules including 3 ISO-7 Tissue culture manufacturing suits. This facility will serve the NCI Surgery Branch for production of new cancer treatment drugs
Project Officer: Hamideh Alehossein
Support: Todd Cauffman and Keegan Kinney
Cost: $32M
CQV Completion/Turnover: February 2021